drugset / Trial / NCT02389881
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of multiple doses of TAK-058 in healthy non-elderly and elderly participants.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-058 | Unknown | 25 mg | Oral |
| Subject | TAK-058 | Unknown | 75 mg | Oral |
| Subject | TAK-058 | Unknown | 150 mg | Oral |
| Subject | TAK-058 | Unknown | 300 mg | Oral |
Indications
No indication recorded.